Educational protocol hub
AHK-Cu: protocol variants and reconstitution resources
Educational hub for AHK-Cu, grouping 3 available protocol variants with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available AHK-Cu protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
AHK-Cu
AHK-Cu is the copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine (Ala-His-Lys-Cu²⁺) and a structural analogue of GHK-Cu. It is researched primarily in hair-follicle and skin biology. Available evidence is mainly ex vivo and in vitro; there is no standardized human injectable dose, and AHK-Cu is not approved by the FDA or EMA. Research sources report subcutaneous administration of 1 mg to 2 mg, once daily.
View protocolAHK-Cu
AHK-Cu is the copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine (Ala-His-Lys-Cu²⁺) and a structural analogue of GHK-Cu. It is researched primarily in hair-follicle and skin biology. Available evidence is mainly ex vivo and in vitro; there is no standardized human injectable dose, and AHK-Cu is not approved by the FDA or EMA. Research sources report subcutaneous administration of 1 mg to 2 mg, once daily.
View protocolAHK-Cu
AHK-Cu is the copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine (Ala-His-Lys-Cu²⁺) and a structural analogue of GHK-Cu. It is researched primarily in hair-follicle and skin biology. Available evidence is mainly ex vivo and in vitro; there is no standardized human injectable dose, and AHK-Cu is not approved by the FDA or EMA. Research sources report subcutaneous administration of 1 mg to 2 mg, once daily.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Archives of Pharmacal Research (2007) — Pyo et al. — AHK-Cu in human hair follicles ex vivo and dermal papilla cells in vitro (PMID 17703734)
View Source - Pickart patent literature — US5538945A — Preclinical copper-peptide research, including AHK:Cu, in animal hair-growth models
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.